In this episode of Debatable at Best, Ray Ali and Amol Gharte tackle three forces quietly reshaping everyday life: health, money, and control.

Ray opens with GLP-1 drugs — the weight-loss and diabetes medications reshaping healthcare, behavior, and expectations around obesity. We debate whether these drugs are a genuine medical breakthrough or a costly long-term dependency, touching on effectiveness, side effects, access, and what happens when people stop taking them.

Amol then shifts the conversation to privacy and stablecoins, breaking down why digital money, surveillance, and control over financial data are becoming inseparable — and why stablecoins sit at the center of future debates around trust, regulation, and personal freedom.

We close with student loans, where the restart of collections, shifting repayment rules, and lo ...